A new ultrasensitive diagnostic device could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions...
Read More »Microfluidic on-demand engineering of exosomes towards cancer immunotherapy
Extracellular Vesicles (EVs), particularly exosomes (30-150 nm), are an emerging delivery system in mediating cellular communications, which have been observed for priming immune responses by presenting parent cell signaling proteins or tumor antigens...
Read More »Microfluidic engineering of exosomes – editing cellular messages for precision therapeutics.
Study of extracellular vesicles (EVs), particularly exosomes, holds significant promise; however, it is technically challenging to define these small and molecularly diverse nanovesicles. With intrinsic molecular...
Read More »Ultrasensitive Microfluidic Analysis of Circulating Exosomes Using Nanostructured Graphene Oxide/Polydopamine Coating
Exosomes are cell-derived nanosized vesicles that have been recently recognized as new mediators for many cellular processes and potential biomarkers for non-invasive disease diagnosis and monitoring of treatment response. To better elucidate the biology and clinical value of exosomes, there ...
Read More »New ‘lab-on-a-chip’ could revolutionize early diagnosis of cancer
LAWRENCE — Scientists have been laboring to detect cancer and a host of other diseases in people using promising new biomarkers called “exosomes.” Indeed, Popular Science magazine named exosome-based cancer diagnostics one of the 20 breakthroughs that will shape the world ...
Read More »